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Statistics and research for the Department of Health, Social Services and Public Safety is provided by Information 
Analysis Directorate (IAD). It comprises four statistical sections: Hospital Information, Community Information, 
Public Health Information & Research and Project Support Analysis.  
 
IAD is responsible for compiling, processing, analysing, interpreting and disseminating a wide range of statistics 
covering health and social care.  
 
The statisticians within IAD are out-posted from the Northern Ireland Statistics & Research Agency (NISRA) and our 
statistics are produced in accordance with the principles and protocols set out in the Code of Practice for Official 
Statistics.  
 
About Public Health Information and Research Branch  
The role of Public Health Information and Research Branch (PHIRB) is to support the public health survey function 
and to provide support on public health issues within the Department. The head of the branch is the Principal 
Statistician, Mr. Bill Stewart. 
 
In support of the public health survey function, PHIRB is involved in the commissioning, managing and publishing of 
results from departmental funded surveys, such as the Health Survey Northern Ireland, All Ireland Drug Prevalence 
Survey, Young Persons Behaviour & Attitudes Survey, and the Adult Drinking Patterns Survey. 
 
PHIRB also has responsibility for the management of a programme of patient experience surveys across the Health 
and Social Care sector. 
 
PHIRB provides support to a range of key DHSSPS strategies including Making Life Better, a 10 year cross-
departmental public health strategic framework as well as a range of other departmental strategies such as those 
dealing with suicide, sexual health, breastfeeding, tobacco control and obesity prevention.  It also has a key role in 
supporting the Alcohol and Drug New Strategic Direction 2011-2016, by maintaining and developing key 
departmental databases such as, the Drug Misuse Database, Impact Measurement Tool and the Census of Drug & 
Alcohol Treatment Services, which are all used to monitor drug misuse and treatments across Northern Ireland. 
 
The branch also houses the NI Health and Social Care Inequalities Monitoring System which covers a range of 
different health inequality/equality based projects conducted for both the region as well as for more localised area 
levels.  
 
Statistics from the Northern Ireland Drug Misuse Database: 1 April 2014 – 31 March 2015 
This bulletin summarises information on people presenting to services with problem drug misuse and relates to the 
12-month period ending 31 March 2015. It is the fourteenth bulletin reporting on information collected through the 
Northern Ireland Drug Misuse Database (DMD), and collects detailed data on those presenting for treatment, 
including information on drugs misused and injecting behaviour. 
 
In Summary: 
 In Northern Ireland in 2014/15, a total of 2,262 clients presented 
to services for problem drug misuse and gave their consent for 
their details to be included in the DMD.  This was 12% lower than 
in 2013/14 (2,574 clients). 
 Four-fifths of clients (80%) were male.  Male clients were 
younger than female clients. For males, 32% were aged 18-25 
and 17% were aged over 40 years old.  For females, 23% were 
aged 18-25 and 32% were aged over 40 years old. 
 Two-fifths of those presenting for treatment (40%) took just one 
drug, while a fifth (21%) took two drugs, 16% took three drugs 
and 23% took four or more drugs. 
 Four-fifths of all clients (79%) used at least one hypnotic drug, 
with 56% of all clients using a hypnotic drug as their main drug of 
misuse. 
 Almost half of all clients (49%) used at least one stimulant drug, 
with it being the main drug for a fifth of all clients (19%).  
 Almost a third of all clients (32%) used at least one opioid 
analgesic drug, with 22% of all clients using one as their main 
drug of misuse.  
 Considering all drugs used by clients, the most commonly 
reported drug was Cannabis (used by 65% of clients) followed by 
Benzodiazepines (used by 36% of clients) and Cocaine (used by 
34% of clients).   
 Cannabis was used by 42% of clients as the main drug of misuse 
in 2014/15, up from 39% in 2013/14.  
 Almost a third of those presenting for treatment (31%) had 
previously received treatment for their drug misuse.   
 The proportion of clients that had ever injected drugs during 
their lifetime stood at 11% in 2014/15.   Injecting was notably 
higher in the Northern Trust (28% of clients) compared with the 
other Trust areas (9-11%).    
 Between 2004/05 and 2014/15, use of Cocaine among clients 
rose from 21% to 34%, while use of Ecstasy (27% to 13%) and 
Heroin (16% to 11%) both fell. 
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Drug User Profile 
In 2014/15, a total of 2,262 clients presented to 
services for problem drug misuse for the first time or 
first time in six months and gave their consent for 
their details to be included in the DMD.  This was 12% 
lower than in 2013/14 (2,574 clients). 
Age of Clients by gender 
Four-fifths of clients (80%) were male.  Male clients 
were on average younger than female clients.  More 
than four-fifths of males (83%) were aged under 40 
compared with two-thirds of females (68%).  
 
Almost a quarter of all clients were in prison, with the 
majority of these being male (94%) and aged under 40 
(86%). 
 
Drugs Used 
Considering the range of drugs used by clients, 
Cannabis was the most commonly reported drug 
(used by 65% of clients) followed by Benzodiazepines 
(36%) and Cocaine (34%). 
 
      Hypnotics      Stimulants      Opiates      Solvents      Other drugs  
Frequency of use 
Four-fifths of all users (81%) used at least one drug on 
a daily basis and a further 11% used at least one drug 
weekly.  The proportion of clients that had taken at 
least one drug in the last four weeks ranged from 77% 
in the Belfast Trust to 90% in the South Eastern Trust.  
This was true for half of clients in prison. 
  
Number of Drugs used 
Two-fifths of those presenting for treatment (40%) 
took just one drug, while a fifth (21%) took two drugs 
and 23% took four or more drugs. 
There was a marked difference between the number 
of drugs used by clients in prison in comparison with 
those who were not in prison.  Almost half of clients 
not in prison (49%) had one drug of misuse compared 
with 12% of clients in prison.  The proportion of 
clients in prison using five drugs (27%) was four times 
that of clients not in prison (7%). 
 
 
 
Drug Combinations 
Drug combinations used varied between clients in 
prison and clients not in prison.  Almost three-fifths of 
non-prison clients (58%) used just one type of drug 
only compared with 18% of prison clients (e.g. they 
took hypnotics or stimulants only although they may 
have taken more than one individual drug of that 
type).  More than two-fifths of prison clients (43%) 
took a combination of two types of drug, while 35% 
took a combination of three types of drug.   
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Nearly two-fifths of non-prison clients (37%) used 
hypnotic drugs only, with a fifth taking a combination 
of hypnotics and stimulants.  This compared with 33% 
of clients in prison that used a combination of 
hypnotics, stimulants and opioids and a further 27% 
that used a combination of hypnotics and stimulants. 
 
Use of Prescription drugs 
A fifth of all clients (22%) took at least one prescribed 
drug, with females (37%) more likely to do so than 
males (18%).  The relatively high proportion of 
females that took prescribed drugs in the South 
Eastern Trust (74%) was due to some extent to their 
specialised Benzodiazepine projects that are in place. 
 
Problem Use of Alcohol 
Problem alcohol use was reported by a quarter of 
clients (27%) ranging from 8% of those in Prison to 
37% in the South Eastern Trust.  Overall, 13% of 
clients reported alcohol as their main problem 
ranging from 6% in both the Northern Trust and in 
prisons to 21% of clients in the Western Trust. 
 
Proposed Treatment 
Clients can be offered one or more treatment 
services.  Two-thirds of clients (63%) were offered one 
treatment while a further 22% were offered two 
treatments. The most common treatment offered was 
counselling (69%) followed by Education / Information 
(43%) and mentoring (8%). 
 
Previous treatment 
Almost a third of those presenting for treatment 
(31%) had previously received treatment for their 
drug misuse.  More than two-thirds of those 
previously treated (71%) had received counselling as 
part of their treatment. 
 
Injecting History 
A tenth of clients (11%) have injected their drugs at 
some point.  Injecting was notably higher in the 
Northern Trust (28% of clients) than in all other 
Trusts.   
While Heroin use among clients in the Northern Trust 
(17%) was higher than all other Trusts (4%-10%), it 
was less than that of clients in prison (20%).  Clients in 
prison however were more likely to smoke heroin 
(57%) than inject it (39%).  
 
Of those who had ever injected, a quarter had shared 
injecting paraphernalia (27%).  Females (44%) were 
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four times more likely to have done so than males 
(11%).  A third of these clients had injected in the last 
four weeks (35%).  Three-fifths of those with an 
injecting history had been tested for HIV (60%), 
Hepatitis C (60%) and Hepatitis B (61%).  Almost a 
third (30%) had been fully vaccinated against 
Hepatitis B, while a further 7% had been partly 
vaccinated. 
Attendance 
Two-fifths of all clients chose by themselves to attend 
for treatment (40%), while another two-fifths were 
required by others to attend (40%) and a fifth (20%) 
were persuaded by others.   
Referral 
Almost two-fifths of referrals came from GPs (36%), 
while a third came through the legal system (34%) 
and a tenth were self-referrals (10%). 
 
  
Attendance reason 
Clients could state one or more reasons for 
attendance for treatment.  The most common reason 
given was psychological (47%), followed by family / 
relationships (43%), legal (40%) and medical reasons 
(16%).   
Dependent children 
The proportion of clients that reported having 
dependent children ranged from 27% of those in the 
Southern Trust to two-fifths of those in the Northern 
and Belfast Trust areas (39%).  
Employment status 
Over one-tenth of clients (13%) were in employment 
and 5% were students.  Almost half were unemployed 
(47%), a further 6% were receiving other benefits, 2% 
were young people not in employment, education or 
training and 2% were retired.  Almost a quarter of all 
clients were in prison or a young offender centre.   
Just over a quarter of clients (28%) had worked in the 
last twelve months. 
Use of Hypnotic Drugs 
Use by gender 
Hypnotic drugs were the most commonly used type of 
drug by both males (81%) and females (75%).  
However, the use of individual hypnotic drugs varied 
greatly by gender.  Males were more likely to use 
Cannabis (70%) than females (44%) while females 
were slightly more likely to use Benzodiazepines 
(40%) than males (35%). 
 
Females (54%) were four times as likely to obtain 
Benzodiazepines solely on prescription than males 
(13%). 
Frequency of use 
The majority of those using other hypnotics (95%) and 
Cannabis (79%) did so, on a daily basis.  This was true 
for two-thirds of those using Benzodiazepines (66%). 
Route of Use 
All clients that used Benzodiazepines and Other 
Hypnotics took these orally (both 100%) while the 
main route of use for Cannabis was smoking (87%). 
Age of first use  
The majority of clients using Cannabis (83%) had first 
taken this drug under the age of 18. Over half of 
clients using other hypnotics (54%) first used these 
drugs aged 40 or over.   
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Age at presentation for treatment  
As with first use, age at presentation for treatment for 
Cannabis was younger with just under half of clients 
aged 25 and under compared with just over a third of 
clients using Benzodiazepines and 7% of clients using 
other hypnotics. 
 
  
Use by Trust 
Hypnotic drugs were used by the majority of clients 
ranging from 71% of those in the Southern Trust to 
91% of those in prison.  However the level of use of 
individual hypnotic drugs varied widely across Trusts.  
Cannabis was the most commonly reported drug 
across all Trust areas with the exception of the South 
Eastern Trust area. Use ranged from 37% of clients in 
the South Eastern Trust area to 71% in the Northern 
Trust area.  Cannabis was used by four-fifths of all 
clients in prison. 
Over half of those in prison (55%) and those in the 
South Eastern Trust area (53%) reported having used 
Benzodiazepines.  Use of other hypnotics was 
relatively low in all Trusts with the exception of the 
South Eastern Trust area (10%), with the vast majority 
of these having been prescribed. 
 
Comparison of use between 2013/14 and 2014/15  
Use of hypnotics among male clients fell from 83% in 
2013/14 to 81% in 2014/15, while there was no 
substantial change in use of hypnotics among female 
clients.  Use of Cannabis increased from 62% in 
2013/14 to 65% in 2014/15, while use of Other 
Hypnotics fell from 6% to 2%.  There was no change in 
the use of Benzodiazepines.   
 
Use of Stimulant Drugs 
Use by gender 
Male clients (53%) were more likely to use stimulant 
drugs than female clients (33%).  Use of Cocaine 
among males (38%) was double that of females (19%). 
 
Frequency of use 
Over three-quarters of those who used New 
Psychoactive Substances did so at least on a weekly 
basis.  This was also true for 71% of clients using 
Methedrone / Mephedrone, 61% of clients using 
Cocaine, 54% of Speed users, 51% of Ecstasy users 
and 51% of clients using other stimulant drugs.   
Route of Use 
The main route of use for Cocaine (86%) and 
Methedrone / Mephedrone (70%) was by sniffing, 
while the main route of use for Ecstasy (97%) was 
orally.  
Age of first use  
Two-thirds of those who used Ecstasy (66%) and 
three-fifths of those who used New Psychoactive 
Substances first used it at under eighteen years of 
age. For all other stimulant drugs, first use occurred 
for the highest percentage of clients between the age 
of 18 and 25 years.   
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Age at presentation for treatment  
Three-quarters of clients using New Psychoactive 
Substances presented for treatment aged under 25 
years.   This was higher than for Methedrone / 
Mephedrone (55%).  Around half of those who used 
Ecstasy (49%), Cocaine (50%), Speed (53%) and Other 
Stimulants (57%) presented for treatment at between 
18 and 25 years.  
 
 Use by Trust 
Use of any stimulant drug varied across the Trust 
areas ranging from a third of clients (29%) within the 
South Eastern Trust to over half of clients (54%) in the 
Western Trust.  Almost three-quarters of clients in 
prison (71%) used stimulant drugs. 
Cocaine was used by three-fifths of clients in prison 
(58%), while its use ranged from 14% of clients in the 
Northern Trust to 33% in the Southern Trust area.   
Methedrone / Mephedrone was the second most 
commonly reported drug used in Western Trust area 
(31%).   
Almost a quarter of clients in prison (23%) reported 
having used Ecstasy.  Outside prison, the highest use 
of Ecstasy was reported amongst clients in the Belfast 
Trust area (13%).  Speed was used by 14% of clients in 
Prison, but by 2-3% of clients in all Trust areas. 
The use of New Psychoactive Substances was highest 
in the Western Trust (11%) while it was used by 2-7% 
of clients in other Trust areas.   
  
Comparison of use between 2013/14 and 2014/15 
Use of Stimulants among females increased from 27% 
in 2013/14 to 33% in 2014/15, while there was no 
significant change in use among males.  Use of 
Cocaine increased from 30% to 34% of clients while 
use of Ecstasy decreased from 17% to 13% of clients.   
 
Use of Opioid Analgesic Drugs 
Use by gender 
The proportion of females using Codeine & 
Paracetamol (10%) and Codeine (8%) was more than 
double that of males (4% and 3% respectively).  
Conversely, more males (12%) used Tramadol than 
females (8%). 
 
Frequency of use 
The majority of those using opioid analgesics used 
them on a daily basis. Over four-fifths of Codeine & 
Paracetamol users (88%) and Codeine users (82%), 
and around two-thirds of Tramadol users (69%) and 
Other Opiate users (66%) took these drugs daily. 
Route of Use 
The main route of use for Codeine & Paracetamol 
(99%), Tramadol (99%), Codeine (97%) and Other 
Opiates (73%) was orally.  Just over half of Heroin 
users (52%) injected it, while 42% smoked it. 
Age of first use  
The highest proportion of clients first used an opioid 
analgesic drug between the age of 18 and 25 years.  
Over half of clients (53%) with problem Heroin use 
first used it at this age.    
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 Age at presentation for treatment  
The highest proportion of clients using each opioid 
analgesic drug presented for treatment aged between 
26 and 39 years.  
 
 
Use by Trust 
Use of opioid analgesic drugs was highest in prisons 
(55%).  Use within the Northern Trust area (38%) was 
higher than in the other Trust areas (20-25%).   
A third of clients in prisons (31%) used Tramadol, 
compared with just 3-8% of clients within Trusts.   
Use of Heroin ranged from 4% in the Western Trust to 
17% of clients in the Northern Trust.  A fifth of prison 
clients (20%) used Heroin. 
  
Comparison of use between 2013/14 and 2014/15 
Overall use of opioid analgesic drugs among clients 
rose from 29% in 2013/14 to 32% in 2014/15.  Use of 
Tramadol among clients also rose from 10% to 12% 
over the same period. 
Use of Solvents / Other Drugs 
Solvents  
Solvents were used by just 1% of all clients in the 
region.   Two-thirds of users (63%) first used them 
under the age of sixteen.  Just over half of solvent 
users (53%) used it at least on a weekly basis.  The 
route of use for solvents for the majority of clients 
was sniffing (94%). 
Other drugs  
The other drugs category includes hallucinogens, 
steroids and other drugs rarely reported by clients.  
Other drugs were used by 10% of clients.  Use across 
the Trusts varied from 7% of clients in the Southern 
Trust area to 14% in the Northern Trust.  Other drugs 
were most likely to be used as a fourth or fifth drug 
rather than as a main drug.  Almost half of those who 
used these drugs did so on a daily basis. 
 
Comparison of use in 2014/15 with 2004/05 
The number of clients recorded in treatment for drug 
misuse has risen from 1,746 in 2004/05 to 2,262 in 
2014/15.  This increase can mainly be attributed to 
reported increases in the Belfast Trust and Prisons.  
However those reported to be in treatment within the 
Northern Trust area have halved over the period. 
 
There was little difference in the use of Hypnotic 
drugs by clients between 2004/05 and 2014/15, while 
the use of Stimulants increased from 40% to 49% and 
Opioid Analgesics from 27% to 32%. 
 
Between 2004/05 and 2014/15, Use of cocaine 
increased from 21% of clients to 34%, while use of 
Ecstasy halved from 27% of clients to 13%.  Use of 
Heroin fell from 16% of clients to 11%.  Alongside this, 
the proportion of clients who had ever injected also 
fell from 17% to 11%. 
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Notes to Tables 
1. A dashed line (-) represents a cell count of less than five.  This is in order to avoid issues involving personal 
disclosure, where it may be possible to identify an individual from the data provided.  All percentages are 
rounded to the nearest percentage point. 
2. A DMD form is completed for every client who presents at an Agency with a drug related problem for treatment.  
Clients must give their consent for data on the form to be used on the DMD (Consent was withheld for a total of 
79 DMD forms in 2014/15).  Only those problem drug users attending for the very first time or those who have 
not attended for treatment within the previous six months are recorded on the DMD.  This means that a small 
number of clients may be recorded twice on the DMD within one year (45 clients in 2014/15).   
3. Services available across Trusts vary and this may be reflected in the drugs misused.  For example, where special 
Benzodiazepines Projects exist, there will be greater proportions of clients presenting for treatment for problem 
Benzodiazepines use (i.e. in the South Eastern Trust area). 
4. Hypnotic drugs include Cannabis, Benzodiazepines and other Hypnotics.  Stimulant drugs include Cocaine, 
Ecstasy, Methedrone / Mephedrone, Speed, New Psychoactive Substances and other Stimulants.  Opioid 
Analgesics include Tramadol, Heroin, Codeine & Paracetamol, Codeine and other Opiates. 
 
Table 1:  Drug User Profile by Trust 
Trust Area Belfast Northern 
South 
Eastern Southern Western Prison Total 
Number of users within Trust 
Number of users in Trust 
(Headcount) 795 136 326 152 310 543 2,262 
% of all users on DMD 35.1 6.0 14.4 6.7 13.7 24.0 100.0 
Gender of users % 
Males (Headcount) 612 113 214 120 231 510 1,800 
Females (Headcount) 183 23 112 32 79 33 462 
% Male within Trust 77.0 83.1 65.6 78.9 74.5 93.9 79.6 
% Female within Trust 23.0 16.9 34.4 21.1 25.5 6.1 20.4 
Age of male users % 
Under 18 years 6.5 30.1 7.9 10.0 11.7 0.0 7.2 
18-25 years 29.6 23.0 22.0 31.7 35.5 38.0 31.6 
26-39 years 45.9 41.6 37.9 43.3 36.8 48.2 44.0 
40 years and over 18.0 5.3 32.2 15.0 16.0 13.7 17.2 
Age of female users % 
Under 18 years 9.3 26.1 0.0 - 7.6 0.0 7.1 
18-25 years 27.3 30.4 5.4 31.3 30.4 27.3 22.9 
26-39 years 39.3 26.1 30.4 37.5 44.3 45.5 37.7 
40 years and over 24.0 - 64.3 18.8 17.7 27.3 32.3 
Age of all users % 
Under 18 years 7.2 29.4 5.2 10.5 10.6 0.0 7.2 
18-25 years 29.1 24.3 16.3 31.6 34.2 37.4 29.8 
26-39 years 44.4 39.0 35.3 42.1 38.7 48.1 42.7 
40 years and over 19.4 7.4 43.3 15.8 16.5 14.5 20.3 
Drug type for male users % 
Hypnotic drugs 75.0 81.4 79.9 69.2 78.4 91.2 80.6 
Stimulants 44.0 36.3 39.3 52.5 56.3 71.4 52.8 
Opioid Analgesics 21.2 35.4 25.2 16.7 16.0 53.3 30.7 
Solvents / Other Drugs 11.6 14.2 16.4 9.2 8.2 8.2 10.8 
Drug type for female users % 
Hypnotics 73.2 65.2 85.7 78.1 62.0 84.8 75.1 
Stimulants 35.5 21.7 10.7 31.3 48.1 66.7 32.9 
Opioid Analgesics 35.5 47.8 20.5 31.3 35.4 84.8 35.7 
Solvents / Other Drugs 13.7 26.1 8.0 - 13.9 - 11.5 
Drug type for all users % 
Hypnotic drugs 74.6 78.7 81.9 71.1 74.2 90.8 79.5 
Stimulants 42.0 33.8 29.4 48.0 54.2 71.1 48.8 
Opioid Analgesics 24.5 37.5 23.6 19.7 21.0 55.2 31.7 
Solvents / Other Drugs 12.1 16.2 13.5 7.9 9.7 7.9 10.9 
Prescribed drugs % 
At least one drug prescribed 13.7 12.5 47.5 7.9 11.3 30.8 21.9 
Problem Alcohol Use %        
Problem alcohol use reported 31.8 25.7 37.4 32.9 35.5 8.1 27.1 
Alcohol main problem 15.6 5.9 15.6 17.8 21.0 5.5 13.5 
 
Table 1:  Drug User Profile by Trust (Continued) 
Trust Area Belfast Northern 
South 
Eastern Southern Western Prison Total 
Drugs used % 
Cannabis 63.1 71.3 36.8 67.1 67.7 79.2 64.6 
Benzodiazepines 28.1 21.3 53.4 12.5 21.0 54.9 35.7 
Other Hypnotics - 0.0 9.8 0.0 - - 1.8 
Cocaine 32.1 14.0 17.8 32.9 23.2 58.2 34.0 
Methedrone/Mephedrone 12.8 19.1 9.8 23.0 31.0 15.8 16.7 
Ecstasy 12.6 - 7.7 7.9 8.1 23.0 12.8 
Speed 2.9 - 1.8 3.3 2.9 14.4 5.5 
New Psychoactive Substances 2.0 6.6 5.5 3.3 11.0 - 3.7 
Other Stimulants 3.6 - 4.0 - 4.2 1.5 3.0 
Tramadol 5.5 8.1 5.8 3.3 5.5 30.8 11.6 
Heroin 9.9 16.9 4.9 8.6 4.2 19.9 11.1 
Codeine & Paracetamol 4.0 4.4 7.7 - 6.8 6.1 5.3 
Codeine  5.2 8.8 3.4 - 1.6 4.8 4.4 
Other Opiates 5.8 11.8 8.6 10.5 8.1 11.0 8.4 
Solvents 1.4 - - - - 2.2 1.4 
Other Drugs 10.9 14.0 12.9 6.6 9.4 5.7 9.6 
Number of drugs used % 
One drug 49.9 42.6 50.3 52.6 43.5 11.8 39.7 
Two drugs 20.0 21.3 20.6 20.4 24.2 20.8 21.0 
Three drugs 13.7 20.6 12.0 17.1 16.5 19.7 15.9 
Four drugs 9.3 10.3 9.2 6.6 7.7 21.0 11.8 
Five drugs 7.0 5.1 8.0 3.3 8.1 26.7 11.7 
Frequency of use % 
Daily 77.2 75.0 84.4 65.1 79.4 91.5 81.0 
Weekly 14.7 14.7 10.1 18.4 14.2 2.8 11.4 
Monthly 1.3 - - 3.3 1.6 - 1.2 
Occasionally 6.7 9.6 4.6 13.2 4.8 5.2 6.4 
At least 1 drug used in last 4 weeks 76.9 88.2 90.2 80.3 83.5 51.4 74.5 
Required / Persuaded / Own choice to attend (%) 
Wholly own choice 51.1 66.2 29.1 67.8 54.2 8.3 40.1 
Persuaded by others 22.3 22.8 29.4 26.3 35.8 - 20.2 
Required by others 26.7 11.0 41.4 5.9 10.0 91.2 39.7 
Referral By (%) 
GP 34.1 33.8 73.9 55.3 51.9 - 35.5 
Psychiatric / Mental Health Service / 
Hospital 
5.2 13.2 12.6 19.7 14.5 0.0 7.7 
Addiction Treatment Services 6.5 3.7 1.5 5.3 - 0.0 3.1 
Social Services 4.3 9.6 - 3.9 3.5 0.0 2.9 
Prison / YOC / Probation / Drug 
Arrest Referral / Legal requirement 
21.6 18.4 1.8 4.6 9.0 98.5 34.2 
Self 18.0 8.8 5.8 - 10.3 1.3 9.5 
Family / Friend 3.3 5.9 3.1 - 3.9 0.0 2.7 
Other 7.0 6.6 - 6.6 6.5 0.0 4.3 
 
Table 1:  Drug User Profile by Trust (Continued) 
Trust Area Belfast Northern 
South 
Eastern Southern Western Prison Total 
Reason for attendance (%) 
Legal 31.8 28.7 12.6 8.6 21.0 92.6 40.4 
Psychological 56.5 56.6 74.5 49.3 60.3 5.3 46.9 
Family/Relationships 48.7 58.8 58.6 59.2 69.0 2.0 43.0 
Medical  - e.g. Detoxification 19.2 23.5 20.9 30.9 16.8 2.4 16.1 
Financial 20.0 17.6 14.7 7.9 23.2 1.5 14.3 
Job 11.8 8.8 6.1 7.2 9.4 - 7.4 
Any other reason given  13.6 8.8 21.2 3.3 9.7 - 10.0 
Proposed Treatment (%) 
Counselling 59.2 56.6 43.6 57.9 87.7 95.0 69.2 
Education/Information 43.4 75.7 79.4 42.8 55.5 4.8 42.9 
Mentoring 12.2 12.5 7.1 13.2 10.0 - 8.4 
Family Support 5.3 14.7 4.6 5.9 21.9 0.0 6.8 
Advised screening for HIV / HEP B/C 9.6 14.0 2.1 4.6 5.8 4.8 6.8 
Detoxification 6.5 8.1 7.7 5.3 12.6 1.8 6.4 
Substitute Prescribing 5.3 22.8 6.1 9.2 3.5 3.1 6.0 
Prescribing Contract 2.0 8.8 2.1 - 4.2 1.7 2.7 
Throughcare 1.0 3.7 10.7 - 0.0 - 2.3 
Rehabilitation - 4.4 2.5 - - 0.0 1.0 
Other 7.2 10.3 2.1 - 8.1 - 4.8 
Legal Status (%) 
No Legal Status 65.8 61.0 80.7 77.0 78.7 0.0 54.4 
In Prison - 0.0 - 0.0 0.0 100.0 24.2 
Community Supervision 17.4 19.9 5.8 3.9 5.5 0.0 9.2 
Trial Pending 6.3 5.1 5.2 8.6 7.4 - 5.0 
Other 10.4 16.9 7.7 11.2 9.7 - 8.0 
Living With (%) 
Prison / YOC 0.6 0.0 - 0.0 0.0 100.0 24.3 
Alone 31.1 22.1 24.8 30.9 31.6 0.0 22.2 
Parents / Parents & siblings 34.1 48.5 29.8 36.8 40.0 0.0 27.1 
Spouse/ partner only 6.9 3.7 19.0 7.9 6.5 0.0 6.8 
Spouse/ partner / Dep. children 7.4 6.6 12.6 9.2 7.4 0.0 6.5 
Dependent children only 2.3 - 4.3 3.3 2.9 0.0 2.1 
Other family 2.5 6.6 3.7 3.9 3.5 0.0 2.6 
Hostel / Sheltered Accom. / In Care 10.6 4.4 1.8 3.9 5.5 0.0 5.3 
Other 4.5 7.4 3.7 3.9 2.6 0.0 3.2 
Employment Status (%) 
Unemployed (JSA) 67.3 44.9 47.2 67.1 67.7 0.0 46.9 
Receiving Other Benefits 5.9 11.8 16.6 3.3 2.6 0.0 5.7 
Not in Employment Educ or Training 2.8 3.7 - - 1.9 0.0 1.6 
Retired / Receiving pension - 0.0 10.7 0.0 - 0.0 1.8 
In Employment 16.6 12.5 18.1 17.8 16.1 0.0 12.6 
Student 5.0 21.3 5.2 9.9 7.4 0.0 5.5 
On Govt training scheme 1.4 5.9 - - 3.5 0.0 1.5 
In prison - 0.0 - 0.0 0.0 100.0 24.2 
Worked in last 12 months 25.2 22.1 27.3 23.0 26.5 37.9 28.4 
Table 2:  Treatment History by Trust 
Trust Area Belfast Northern 
South 
Eastern Southern Western Prison Total 
Drug Treatment History 
Ever Treated before (Headcount) 248 55 129 49 106 115 702 
Ever Treated before (%) 31.2 40.4 39.6 32.2 34.2 21.2 31.0 
Of those who have previously been treated - Age first treated (%)  
Under 18 years 10.1 12.7 - - 10.4 12.2 8.7 
18-21 years 21.8 25.5 15.5 28.6 17.9 30.4 22.2 
22-25 years 17.3 20.0 12.4 22.4 13.2 13.9 15.8 
26 years and over 41.9 36.4 62.8 38.8 54.7 20.9 43.6 
Unknown 8.9 - 7.8 - - 22.6 9.7 
Of those who have previously been treated - Previous Treatment (%)  
Counselling 69.4 49.1 76.0 55.1 88.7 71.3 71.2 
Detoxification 19.0 25.5 30.2 12.2 16.0 7.8 18.8 
Substitute Prescribing 13.7 47.3 10.1 28.6 10.4 17.4 16.8 
Rehabilitation 9.7 10.9 21.7 - 6.6 - 10.4 
Prescribing Contact 4.0 12.7 6.2 - 8.5 7.8 6.3 
 
Table 3:  Injecting History by Trust 
       
 Trust Area Belfast Northern 
South 
Eastern Southern Western Prison Total 
Injecting history: 
Ever Injected (Headcount) 80 38 37 16 30 55 256 
Ever Injected (%) 10.1 27.9 11.3 10.5 9.7 10.1 11.3 
Gender (%) 
Ever Injected - Males 10.1 26.5 13.1 9.2 11.3 8.6 11.2 
Ever Injected - Females 9.8 34.8 8.0 15.6 - 33.3 11.9 
Of those who have injected - Age first injected (%) 
Under 18 years 6.3 - - 0.0 - 18.2 9.8 
18-21 years 25.0 47.4 21.6 - 26.7 20.0 26.2 
22-25 years 30.0 21.1 32.4 50.0 20.0 25.5 28.1 
26 years and over 32.5 21.1 37.8 - 33.3 29.1 30.1 
Unknown 6.3 - 0.0 - - - 5.9 
Of those who have injected - Testing for HIV / Hepatitis / Sharing History / Use in last 4 weeks (%) 
HIV Tested 63.8 73.7 45.9 68.8 73.3 43.6 59.8 
Hepatitis C Tested 63.8 73.7 45.9 68.8 73.3 43.6 59.8 
Hepatitis B Tested 65.0 76.3 45.9 68.8 73.3 43.6 60.5 
Hepatitis B Fully Vaccinated 31.3 44.7 18.9 - 23.3 29.1 29.7 
Hepatitis B Part Vaccinated 8.8 - 0.0 - - - 7.0 
Ever Shared 32.5 28.9 16.2 43.8 23.3 20.0 26.6 
Injected in the last 4 weeks 53.8 42.1 18.9 37.5 23.3 18.2 34.8 
Of those who have injected in last 4 weeks – In last 4 weeks: (%) 
Always used new equipment  79.1 62.5 100.0 100.0 100.0 60.0 78.7 
Rotated sites 86.0 62.5 85.7 83.3 85.7 60.0 78.7 
Used Needle & Syringe Exchange  93.0 75.0 85.7 83.3 85.7 - 80.9 
Filtered  88.4 75.0 - 83.3 - - 71.9 
Bleached  53.5 31.3 - 83.3 0.0 - 43.8 
Shared equipment  18.6 - 0.0 - 0.0 - 16.9 
Table 4:  Main / Second / Third / Fourth / Fifth Drugs and their use 
 Drug  Main Drug Second Drug  Third Drug  Fourth Drug  Fifth Drug  
Number of users 
Number of users on DMD 2,262 1,364 890 530 264 
% of users on DMD 100.0 60.3 39.3 23.4 11.7 
Gender of users 
Males (Headcount) 1,800 1,133 744 444 222 
Females (Headcount) 462 231 146 86 42 
% Male 79.6 83.1 83.6 83.8 84.1 
% Female 20.4 16.9 16.4 16.2 15.9 
% of all males registered 100.0 62.9 41.3 24.7 12.3 
% of all females registered 100.0 50.0 31.6 18.6 9.1 
Age of users at first face to face % 
Under 18 years 7.2 5.1 4.2 2.6 - 
18-25 years 29.8 34.7 38.4 41.7 43.9 
26-39 years 42.7 45.1 44.8 44.0 45.1 
40 years and over 20.3 15.2 12.6 11.7 9.8 
Age of first use % 
Under 16 years 34.8 26.9 27.0 28.5 25.8 
16-17 years 15.5 21.4 25.2 23.0 22.7 
18-25 years 29.3 32.8 32.6 33.2 36.4 
26-39 years 13.8 13.1 10.9 11.7 11.4 
40 years & over 5.3 4.5 2.8 2.5 3.0 
Not known 1.2 1.2 1.6 1.1 - 
Drug Type for Male users % 
Hypnotics 55.8 39.5 37.8 30.6 24.8 
Stimulants 20.3 41.2 46.1 46.4 45.5 
Opioid Analgesics 21.4 14.8 10.8 14.0 16.7 
Solvents / Other Drugs 2.6 4.4 5.4 9.0 13.1 
Drug Type for Female users % 
Hypnotics 56.7 45.9 23.3 25.6 16.7 
Stimulants 12.8 31.6 41.1 40.7 54.8 
Opioid Analgesics 26.6 16.0 21.9 30.2 23.8 
Solvents / Other Drugs 3.9 6.5 13.7 - - 
Drug % 
Cannabis 41.5 17.9 17.9 17.4 12.5 
Benzodiazepines 13.7 21.4 17.2 12.1 11.0 
Other Hypnotics 0.8 1.3 - - 0.0 
Cocaine 11.1 19.9 17.1 14.5 8.7 
Methedrone/Mephedrone 4.2 8.4 10.8 8.5 9.5 
Ecstasy 0.5 4.5 10.8 14.7 18.6 
Speed 0.7 2.6 3.9 4.9 4.5 
New Psychoactive Substances 1.5 2.4 1.1 1.3 3.0 
Other Stimulants 0.7 1.7 1.6 1.5 2.7 
Tramadol 4.7 4.8 4.7 5.8 6.4 
Heroin 8.4 1.8 1.2 2.6 4.5 
Codeine & Paracetamol 3.0 2.1 1.5 1.5 1.9 
Codeine  2.3 1.8 1.1 1.5 - 
Other Opiates 3.9 4.5 4.0 5.1 3.4 
Solvents 0.3 0.4 1.0 - 2.3 
Other Drugs 2.5 4.4 5.7 7.4 9.5 
Table 4:  Main / Second / Third / Fourth / Fifth Drugs and their use (Continued) 
Drug Number Main Drug Second Drug  Third Drug  Fourth Drug  Fifth Drug  
Frequency of use % 
Daily 73.2 46.6 41.1 33.8 32.2 
Weekly 15.0 25.8 27.5 28.5 29.2 
Monthly 1.7 5.1 5.4 4.3 5.7 
Occasionally 10.1 22.5 25.8 33.4 33.0 
Used in last four weeks 69.0 52.8 42.9 35.7 28.0 
Route of use % 
Oral 39.3 49.9 50.4 51.9 55.7 
Smoke 40.8 19.9 19.3 20.6 16.3 
Sniff 14.4 27.3 28.5 24.2 23.5 
Inject 5.4 2.6 1.7 3.4 4.2 
Other - - 0.0 0.0 - 
Prescribed drugs % 
Only prescribed 9.2 7.8 4.4 2.8 2.3 
Prescribed & others 6.0 5.1 3.5 4.3 1.9 
Treated before % 
Treated before 31.0 34.5 37.5 39.8 44.3 
Of those previously treated: Age at first treatment % 
Under 18 years 8.7 8.9 9.6 10.4 12.0 
18-25 years 38.0 42.0 43.1 45.0 44.4 
26-39 years 32.9 31.6 31.7 26.5 23.9 
40 years and over 10.7 6.6 4.5 3.8 - 
Not known 9.7 10.8 11.1 14.2 17.9 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5:  Drug Combinations 
Number of Drugs Taken  One  Two  Three  Four  Five  
Number of users 
Number of users on DMD 898 474 360 266 264 
% of users on DMD 39.7 21.0 15.9 11.8 11.7 
Gender of users 
Males (Headcount) 667 389 300 222 222 
Females (Headcount) 231 85 60 44 42 
% Male 74.3 82.1 83.3 83.5 84.1 
% Female 25.7 17.9 16.7 16.5 15.9 
% of all males registered 37.1 21.6 16.7 12.3 12.3 
% of all females registered 50.0 18.4 13.0 9.5 9.1 
Age of users at first face to face % 
Under 18 years 10.5 6.8 6.4 4.1 - 
18-25 years 22.4 27.6 33.6 39.5 43.9 
26-39 years 39.1 45.6 46.1 42.9 45.1 
40 years and over 28.1 20.0 13.9 13.5 9.8 
Age of first use % 
Under 16 years 35.5 41.1 55.3 60.2 69.3 
16-17 years 15.0 19.8 19.2 18.8 18.2 
18-25 years 25.1 23.6 19.7 15.4 9.8 
26-39 years 14.9 10.1 3.6 3.8 - 
40 years & over 8.2 4.0 1.4 - - 
Not known 1.2 1.3 - - 0.0 
Drug Combinations 
Hypnotics only 67.0 20.5 - 0.0 0.0 
Stimulants only 15.5 8.9 2.8 - - 
Opioids only 14.1 5.7 1.9 - 0.0 
Solvents / Other Drugs only 3.3 - 0.0 0.0 0.0 
Hypnotics & Stimulants   39.7 45.0 33.8 19.7 
Hypnotics & Opioids   15.2 19.4 8.6 1.9 
Other 2 drug type combination   9.9 11.1 6.0 2.7 
Hypnotics, Stimulants & Opioids     11.1 35.0 45.5 
Hypnotics, Stimulants & 
Solvents/Other Drugs     5.3 7.5 9.8 
Other 3 drug type combination     2.2 4.9 6.8 
4 / 5 drug type combination       1.9 13.3 
Treated before % 
Treated before 25.7 28.9 34.2 35.3 44.3 
Of those previously treated: Age at first treatment % 
Under 18 years 8.2 7.3 8.1 8.5 12.0 
18-25 years 29.9 39.4 39.8 45.7 44.4 
26-39 years 35.5 31.4 40.7 29.8 23.9 
40 years and over 19.0 11.7 5.7 6.4 - 
Not known 7.4 10.2 5.7 9.6 17.9 
Table 6:  Drug Profile 2014/15 
Drug Type Hypnotics Stimulants Opioid Analgesics Solvents Other 
Drugs 
Drug   Cannabis Benzos 
Other 
Hypnotics Cocaine 
Methedrone/ 
Mephedrone Ecstasy Speed 
New 
Psychoactive 
Substances 
Other 
Stimulants Tramadol Heroin 
Codeine & 
Paracetamol Codeine 
Other 
Opiates 
Number of Users 
Number of users on DMD 1,461 808 41 770 377 290 125 84 67 263 252 120 99 191 31 218 
% of total registered on DMD 64.6 35.7 1.8 34.0 16.7 12.8 5.5 3.7 3.0 11.6 11.1 5.3 4.4 8.4 1.4 9.6 
Gender Profile of Users  - % of all registered on DMD of each gender using 
Males (Headcount) 1,258 624 15 683 310 248 104 66 55 224 206 75 62 146 26 170 
Females (Headcount) 203 184 26 87 67 42 21 18 12 39 46 45 37 45 5 48 
% of all males using... 69.9 34.7 0.8 37.9 17.2 13.8 5.8 3.7 3.1 12.4 11.4 4.2 3.4 8.1 1.4 9.4 
% of all females using... 43.9 39.8 5.6 18.8 14.5 9.1 4.5 3.9 2.6 8.4 10.0 9.7 8.0 9.7 1.1 10.4 
Age of users at first face to face % 
Under 18 years 9.9 2.5 0.0 1.8 4.5 1.7 - 35.7 7.5 - - 0.0 - 3.7 16.1 8.7 
18-25 years 37.2 34.2 - 36.8 50.7 39.7 22.4 36.9 23.9 39.5 20.6 25.0 19.2 21.5 19.4 31.7 
26-39 years 39.6 38.7 24.4 49.9 38.7 49.0 52.8 22.6 56.7 44.9 59.5 45.0 53.5 52.4 45.2 45.9 
40 years and over 13.3 24.6 68.3 11.6 6.1 9.7 23.2 - 11.9 14.8 19.4 30.0 26.3 22.5 19.4 13.8 
Age at first use % 
Under 16 years 65.1 20.3 - 16.2 13.3 29.3 25.6 28.6 22.4 13.7 8.7 12.5 16.2 6.3 62.5 14.7 
16-17 years 18.3 19.7 - 25.7 24.1 36.6 20.8 31.0 20.9 14.1 11.1 9.2 13.1 7.3 15.6 15.1 
18-25 years 11.3 35.6 19.5 45.6 41.4 28.3 36.0 20.2 38.8 47.5 52.8 37.5 35.4 38.2 - 41.7 
26-39 years 3.6 13.0 22.0 10.4 16.7 3.4 16.0 16.7 11.9 18.3 25.0 31.7 25.3 35.6 0.0 22.0 
40 years & over 0.8 10.0 53.7 0.8 3.7 - - - - 4.9 2.0 5.8 7.1 11.0 0.0 6.0 
Not known 0.9 1.4 0.0 1.3 - 1.7 - 0.0 - - - - - - - - 
Frequency of use % 
Daily 78.6 66.1 95.1 22.1 27.6 9.3 26.4 54.8 17.9 69.2 56.0 87.5 81.8 66.0 25.0 48.2 
Weekly 10.9 17.0 - 38.7 43.0 41.4 28.0 21.4 32.8 14.1 12.3 5.0 11.1 15.2 28.1 27.1 
Monthly 0.8 2.0 0.0 8.2 8.8 7.6 - 8.3 - 3.0 2.4 - - 2.6 - 4.6 
Occasionally 9.7 15.0 - 31.0 20.7 41.7 43.2 14.3 44.8 13.7 29.4 6.7 5.1 16.2 43.8 20.2 
Used in last four weeks 65.1 65.3 97.6 32.1 46.7 19.0 19.2 71.4 44.8 62.4 46.8 73.3 78.8 69.6 28.1 62.8 
Route of Use % 
Oral 11.9 99.5 100.0 8.2 20.2 96.9 42.4 25.0 44.8 98.9 5.6 99.2 97.0 72.8 - 83.9 
Smoke 87.1 - 0.0 3.8 5.0 - 0.0 57.1 9.0 - 41.7 - 0.0 3.7 0.0 4.6 
Sniff 1.0 0.0 0.0 86.5 70.0 2.4 54.4 16.7 34.3 - - 0.0 - 13.6 93.8 7.3 
Inject 0.0 - 0.0 1.6 4.8 - - - 11.9 0.0 51.6 0.0 0.0 7.3 0.0 3.7 
Other 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 - 0.0 0.0 
Table 7:  Comparison 2012/13, 2013/14 and 2014/15 
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Number of users within Trust 
Number of users in Trust (HC) 1,033 152 446 112 378 703 2,824 983 116 281 189 367 638 2,574 795 136 326 152 310 543 2,262 
% of all users on DMD 34.4 5.1 14.9 3.7 12.6 23.4 94.2 32.8 3.9 9.4 6.3 12.2 21.3 85.8 26.5 4.5 10.9 5.1 10.3 18.1 75.4 
Gender of users % 
Males (Headcount) 731 126 276 97 275 679 2,184 664 94 183 153 272 606 1,972 612 113 214 120 231 510 1,800 
Females (Headcount) 302 26 170 15 103 24 640 319 22 98 36 95 32 602 183 23 112 32 79 33 462 
% Male within Trust 70.8 82.9 61.9 86.6 72.8 96.6 77.3 67.5 81.0 65.1 81.0 74.1 95.0 76.6 77.0 83.1 65.6 78.9 74.5 93.9 79.6 
% Female within Trust 29.2 17.1 38.1 13.4 27.2 3.4 22.7 32.5 19.0 34.9 19.0 25.9 5.0 23.4 23.0 16.9 34.4 21.1 25.5 6.1 20.4 
Age of male users % 
Under 18 years 6.7 27.8 9.8 34.0 10.5 0.0 7.9 5.6 26.6 6.6 11.8 18.8 0.0 7.3 6.5 30.1 7.9 10.0 11.7 0.0 7.2 
18-25 years 31.3 24.6 22.5 23.7 37.5 53.6 37.2 31.5 14.9 26.2 33.3 37.5 46.7 35.9 29.6 23.0 22.0 31.7 35.5 38.0 31.6 
26-39 years 36.8 40.5 35.9 30.9 37.5 36.5 36.6 41.7 44.7 36.6 35.3 30.1 41.3 39.1 45.9 41.6 37.9 43.3 36.8 48.2 44.0 
40 years and over 25.2 7.1 31.9 11.3 14.5 9.9 18.3 21.2 13.8 30.6 19.6 13.6 12.0 17.7 18.0 5.3 32.2 15.0 16.0 13.7 17.2 
Age of female users % 
Under 18 years - 26.9 - - 6.8 0.0 3.9 3.1 - 5.1 - 11.6 0.0 5.1 9.3 26.1 0.0 - 7.6 0.0 7.1 
18-25 years 12.3 - 11.2 53.3 35.0 41.7 17.7 14.4 22.7 12.2 47.2 36.8 40.6 21.3 27.3 30.4 5.4 31.3 30.4 27.3 22.9 
26-39 years 26.8 42.3 17.1 - 37.9 54.2 27.3 29.8 40.9 25.5 27.8 29.5 43.8 30.1 39.3 26.1 30.4 37.5 44.3 45.5 37.7 
40 years and over 59.6 19.2 69.4 - 20.4 - 51.1 52.7 22.7 57.1 19.4 22.1 15.6 43.5 24.0 - 64.3 18.8 17.7 27.3 32.3 
Drug type for male users % 
Hypnotics 84.8 79.4 87.0 78.4 81.8 87.6 85.0 81.5 75.5 83.1 69.9 82.0 89.8 83.1 75.0 81.4 79.9 69.2 78.4 91.2 80.6 
Stimulants 40.4 27.8 27.9 45.4 53.5 63.8 47.2 42.3 38.3 36.1 50.3 55.1 67.5 51.7 44.0 36.3 39.3 52.5 56.3 71.4 52.8 
Opioid Analgesics 16.7 42.1 22.8 20.6 18.9 45.5 28.3 17.3 40.4 26.2 15.0 15.8 52.1 29.6 21.2 35.4 25.2 16.7 16.0 53.3 30.7 
Solvents / Other Drugs 10.1 4.8 8.3 - 11.6 10.2 9.4 13.1 7.4 15.3 6.5 11.4 10.2 11.4 11.6 14.2 16.4 9.2 8.2 8.2 10.8 
Drug type for female users % 
Hypnotics 87.1 53.8 90.0 53.3 59.2 83.3 81.1 80.6 45.5 84.7 63.9 67.4 78.1 76.7 73.2 65.2 85.7 78.1 62.0 84.8 75.1 
Stimulants 12.3 38.5 8.8 60.0 50.5 79.2 22.2 18.2 22.7 18.4 33.3 50.5 75.0 27.4 35.5 21.7 10.7 31.3 48.1 66.7 32.9 
Opioid Analgesics 12.3 46.2 21.2 - 31.1 91.7 22.3 19.7 81.8 24.5 36.1 27.4 59.4 27.1 35.5 47.8 20.5 31.3 35.4 84.8 35.7 
Solvents / Other Drugs 6.0 - 4.7 0.0 14.6 0.0 6.7 4.7 - 5.1 - 16.8 - 6.8 13.7 26.1 8.0 - 13.9 - 11.5 
 
Table 7:  Comparison 2012/13, 2013/14 and 2014/15 (Continued) 
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Drugs used % 
Cannabis 48.8 66.4 34.1 69.6 70.1 75.2 57.7 50.8 61.2 45.9 64.6 69.5 79.6 61.5 63.1 71.3 36.8 67.1 67.7 79.2 64.6 
Benzodiazepines 46.4 21.1 60.3 8.9 16.9 56.0 44.2 35.9 17.2 43.1 10.6 23.2 56.4 37.3 28.1 21.3 53.4 12.5 21.0 54.9 35.7 
Other Hypnotics 7.6 - 8.7 - 1.6 0.9 4.7 10.4 0.0 8.9 - 3.3 1.7 5.9 - 0.0 9.8 0.0 - - 1.8 
Cocaine 20.5 12.5 11.0 22.3 25.4 49.6 26.6 24.1 12.1 19.6 31.2 18.5 53.8 30.1 32.1 14.0 17.8 32.9 23.2 58.2 34.0 
Meth/Mephedrone 8.4 15.8 9.9 35.7 34.1 16.4 15.5 8.2 14.7 13.2 23.3 34.1 14.1 15.3 12.8 19.1 9.8 23.0 31.0 15.8 16.7 
Ecstasy 18.5 13.8 7.6 16.1 26.5 30.6 20.5 15.6 6.9 9.3 14.3 17.4 25.5 17.1 12.6 - 7.7 7.9 8.1 23.0 12.8 
Speed 1.0 - 1.3 - 4.2 11.7 4.1 2.0 - 3.2 - 8.7 16.3 6.6 2.9 - 1.8 3.3 2.9 14.4 5.5 
New Psychoactive Subs 1.8 - 1.1 0.0 3.7 - 1.6 3.9 6.9 3.9 - 12.8 1.3 4.5 2.0 6.6 5.5 3.3 11.0 - 3.7 
Other Stimulants 2.5 9.2 1.6 - 6.6 6.4 4.2 2.4 - 3.2 3.2 5.4 4.2 3.4 3.6 - 4.0 - 4.2 1.5 3.0 
Tramadol 3.8 5.3 8.1 4.5 4.8 24.9 10.0 3.1 5.2 8.5 - 4.6 27.4 9.9 5.5 8.1 5.8 3.3 5.5 30.8 11.6 
Heroin 6.5 20.4 2.9 13.4 6.1 14.1 8.8 6.4 32.8 4.6 8.5 4.4 16.6 9.8 9.9 16.9 4.9 8.6 4.2 19.9 11.1 
Codeine & Paracetamol 3.1 3.9 6.7 - 5.8 6.3 4.8 3.5 - 9.3 - 6.0 6.6 5.1 4.0 4.4 7.7 - 6.8 6.1 5.3 
Codeine 2.0 6.6 3.1 - 1.6 2.8 2.6 4.0 7.8 5.7 6.3 1.9 1.9 3.7 5.2 8.8 3.4 - 1.6 4.8 4.4 
Other Opiates 3.7 12.5 7.8 4.5 9.8 8.7 6.9 4.3 6.9 7.8 4.2 7.9 10.5 6.8 5.8 11.8 8.6 10.5 8.1 11.0 8.4 
Solvents 2.9 - - 0.0 1.6 4.6 2.5 3.4 - - - 1.9 2.4 2.4 1.4 - - - - 2.2 1.4 
Other Drugs 6.5 4.6 6.7 - 10.8 6.1 6.7 7.4 4.3 10.7 5.8 10.9 7.8 8.1 10.9 14.0 12.9 6.6 9.4 5.7 9.6 
Number of drugs used % 
One drug 48.0 44.1 49.1 50.9 39.2 17.8 39.4 51.1 47.4 44.8 52.4 38.7 13.6 39.3 49.9 42.6 50.3 52.6 43.5 11.8 39.7 
Two drugs 27.6 27.6 30.5 23.2 18.8 19.1 24.6 25.8 31.9 26.0 23.3 21.3 18.7 23.5 20.0 21.3 20.6 20.4 24.2 20.8 21.0 
Three drugs 12.3 16.4 10.5 17.0 17.2 18.1 14.5 9.7 10.3 13.2 15.9 16.1 21.2 14.3 13.7 20.6 12.0 17.1 16.5 19.7 15.9 
Four drugs 7.0 6.6 5.4 6.3 14.6 18.5 10.6 6.7 7.8 7.1 6.3 11.2 18.2 10.3 9.3 10.3 9.2 6.6 7.7 21.0 11.8 
Five drugs 5.1 5.3 4.5 - 10.3 26.6 11.0 6.7 - 8.9 - 12.8 28.4 12.7 7.0 5.1 8.0 3.3 8.1 26.7 11.7 
Frequency of use % 
Daily 77.1 69.1 85.2 68.8 71.2 84.8 78.7 77.9 67.2 81.1 68.3 78.5 87.6 79.6 77.2 75.0 84.4 65.1 79.4 91.5 81.0 
Weekly 10.8 23.7 10.3 23.2 17.5 6.8 11.8 9.8 18.1 13.2 21.2 15.5 5.0 11.0 14.7 14.7 10.1 18.4 14.2 2.8 11.4 
Monthly 0.7 - 1.3 - - 0.9 1.0 1.6 - - - 1.4 - 1.2 1.3 - - 3.3 1.6 - 1.2 
Occasionally 11.3 5.3 3.1 6.3 10.3 7.5 8.4 10.4 13.8 4.6 9.0 4.6 6.9 8.1 6.7 9.6 4.6 13.2 4.8 5.2 6.4 
At least 1 drug used in 
last 4 weeks 80.3 89.9 85.7 85.2 39.7 73.5 26.5 79.6 81.0 86.1 74.6 88.8 40.0 71.5 76.9 88.2 90.2 80.3 83.5 51.4 74.5 
Injecting history % 
Ever Injected  7.8 21.7 5.8 10.7 8.5 9.8 9.0 6.8 37.1 8.2 10.1 8.7 11.1 9.9 10.1 27.9 11.3 10.5 9.7 10.1 11.3 
Table 8:  Comparison 2004/05 and 2014/15 
 2004/05 2014/15 
Trust Area Belfast Northern 
South 
Eastern 
Southern Western Prison Total Belfast Northern 
South 
Eastern 
Southern Western Prison Total 
Number of users within Trust 
Number of users in Trust (HC) 516 285 266 145 386 148 1,746 795 136 326 152 310 543 2,262 
% of all users on DMD 17.2 9.5 8.9 4.8 12.9 4.9 58.2 26.5 4.5 10.9 5.1 10.3 18.1 75.4 
Gender of users % 
Males (Headcount) 390 220 181 114 284 130 1,319 612 113 214 120 231 510 1,800 
Females (Headcount) 125 65 85 31 102 18 426 183 23 112 32 79 33 462 
% Male within Trust 75.6 77.2 68.0 78.6 73.6 87.8 75.5 77.0 83.1 65.6 78.9 74.5 93.9 79.6 
% Female within Trust 24.2 22.8 32.0 21.4 26.4 12.2 24.4 23.0 16.9 34.4 21.1 25.5 6.1 20.4 
Age of all users % 
Under 18 years 17.3 12.3 36.8 12.4 18.7 7.4 18.5 7.2 29.4 5.2 10.5 10.6 0.0 7.2 
18-25 years 30.9 32.6 17.3 29.0 32.1 59.5 31.6 29.1 24.3 16.3 31.6 34.2 37.4 29.8 
26-39 years 35.0 44.9 29.7 49.7 31.9 28.4 35.8 44.4 39.0 35.3 42.1 38.7 48.1 42.7 
40 years and over 16.9 10.2 16.2 9.0 17.4 4.7 14.1 19.4 7.4 43.3 15.8 16.5 14.5 20.3 
Drug type for all users % 
Hypnotics  79.7 74.4 80.5 75.9 86.0 81.1 80.1 74.6 78.7 81.9 71.1 74.2 90.8 79.5 
Stimulants 37.4 33.0 21.8 53.8 52.1 52.7 40.2 42.0 33.8 29.4 48.0 54.2 71.1 48.8 
Opioid Analgesics 24.2 57.2 20.7 32.4 15.8 18.2 27.4 24.5 37.5 23.6 19.7 21.0 55.2 31.7 
Solvents / Other Drugs 7.2 2.8 7.9 15.2 11.9 16.2 9.0 12.1 16.2 13.5 7.9 9.7 7.9 10.9 
Drugs used % 
Cannabis 62.2 51.6 59.4 66.2 76.4 68.9 64.1 63.1 71.3 36.8 67.1 67.7 79.2 64.6 
Benzodiazepines 27.3 40.4 23.3 13.1 15.3 28.4 25.1 28.1 21.3 53.4 12.5 21.0 54.9 35.7 
Other Hypnotics 2.3 - 4.1 - - 0.0 1.8 - 0.0 9.8 0.0 - - 1.8 
Cocaine 21.1 20.0 8.3 35.9 19.2 30.4 20.6 32.1 14.0 17.8 32.9 23.2 58.2 34.0 
Methedrone/Mephedrone        12.8 19.1 9.8 23.0 31.0 15.8 16.7 
Ecstasy 22.7 17.2 13.2 43.4 44.0 30.4 27.4 12.6 - 7.7 7.9 8.1 23.0 12.8 
Speed        2.9 - 1.8 3.3 2.9 14.4 5.5 
New Psychoactive Substances        2.0 6.6 5.5 3.3 11.0 - 3.7 
Other Stimulants 11.4 16.1 10.2 20.0 22.0 20.9 15.9 3.6 - 4.0 - 4.2 1.5 3.0 
Tramadol        5.5 8.1 5.8 3.3 5.5 30.8 11.6 
Heroin 13.0 47.4 7.5 17.2 4.7 12.8 16.3 9.9 16.9 4.9 8.6 4.2 19.9 11.1 
Codeine & Paracetamol 3.7 3.9 6.4 9.7 3.4 - 4.4 4.0 4.4 7.7 - 6.8 6.1 5.3 
Codeine 2.1 2.5 - - 3.4 - 2.2 5.2 8.8 3.4 - 1.6 4.8 4.4 
Other Opiates 13.2 29.1 8.6 11.0 6.2 4.7 12.7 5.8 11.8 8.6 10.5 8.1 11.0 8.4 
Solvents 4.1 - 4.9 5.5 4.4 8.8 4.4 1.4 - - - - 2.2 1.4 
Other Drugs 3.3 - 3.4 11.7 8.0 8.1 5.2 10.9 14.0 12.9 6.6 9.4 5.7 9.6 
Number of drugs used % 
One drug 51.7 33.7 63.9 34.5 42.7 33.8 45.7 49.9 42.6 50.3 52.6 43.5 11.8 39.7 
Two drugs 20.5 21.8 21.4 22.8 24.6 26.4 22.5 20.0 21.3 20.6 20.4 24.2 20.8 21.0 
Three drugs 14.9 24.2 7.9 17.9 15.8 23.0 16.5 13.7 20.6 12.0 17.1 16.5 19.7 15.9 
Four drugs 7.6 11.2 3.8 11.0 10.1 10.1 8.6 9.3 10.3 9.2 6.6 7.7 21.0 11.8 
Five drugs 5.2 9.1 3.0 13.8 6.7 6.8 6.7 7.0 5.1 8.0 3.3 8.1 26.7 11.7 
Frequency of use % 
Daily 78.9 88.4 70.7 85.5 84.7 83.1 81.4 77.2 75.0 84.4 65.1 79.4 91.5 81.0 
Weekly 18.0 9.1 20.3 9.7 11.1 11.5 14.1 14.7 14.7 10.1 18.4 14.2 2.8 11.4 
Monthly - - 2.6 - - 0.0 0.9 1.3 - - 3.3 1.6 - 1.2 
Occasionally 2.7 1.8 6.4 3.4 3.4 5.4 3.6 6.7 9.6 4.6 13.2 4.8 5.2 6.4 
At least 1 drug used last 4 wk 85.5 92.6 87.6 90.3 88.6 60.1 85.9 76.9 88.2 90.2 80.3 83.5 51.4 74.5 
Injecting history % 
Ever Injected  15.5 43.2 7.9 18.6 8.3 14.9 17.5 10.1 27.9 11.3 10.5 9.7 10.1 11.3 
In 2004/05, Methedrone/Mephedrone, Speed, New Psychoactive Substances and Tramadol were not named drugs on the DMD. 
